Related Experiment Video
Updated: Feb 26, 2026

Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample
Published on: November 21, 2023
Topoisomerase I deregulation in laryngeal squamous cell carcinomas based on tissue microarray analysis
Theodoros A Papadas1, Evangelos Tsiambas, Nicholas S Mastronikolis
1Department of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras; Patras, Greece.
Topoisomerase I (Topo I) is overexpressed in 64% of laryngeal squamous cell carcinomas (LSCC), correlating with tumor differentiation. This finding suggests Topo I as a potential therapeutic target in LSCC patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Topoisomerases are crucial enzymes regulating DNA topology during essential cellular processes.
- Aberrant Topoisomerase I (Topo I) expression is implicated in various solid malignancies.
- Topo I inhibitors are established chemotherapeutic agents, highlighting its role in cancer treatment.
Purpose of the Study:
- To investigate the expression patterns of Topoisomerase I (Topo I) protein in laryngeal squamous cell carcinomas (LSCC).
- To determine the correlation between Topo I expression and clinicopathological features of LSCC, particularly tumor differentiation.
Main Methods:
- Utilized tissue microarray (TMA) technology for analyzing 50 primary LSCC samples.
- Employed immunohistochemistry with anti-Topo I antibody to assess protein expression levels.
- Implemented digital image analysis for objective quantification of Topo I staining in tumor cell nuclei.
Main Results:
- Topo I protein overexpression was detected in 64% (32/50) of LSCC cases.
- Low Topo I expression was observed in 36% (18/50) of the samples.
- A significant association was found between Topo I expression levels and the grade of tumor differentiation (p=0.021).
Conclusions:
- Topo I overexpression is a frequent event in a significant proportion of LSCC.
- The level of Topo I expression is linked to the differentiation status of laryngeal tumors.
- Further research into the mechanisms of Topo I deregulation is warranted to guide targeted therapy selection in LSCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation

